Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer
- 1 July 2007
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 4 (7) , 415-423
- https://doi.org/10.1038/ncponc0851
Abstract
It is increasingly being recognized that breast cancer does not represent a single homogeneous disease; instead, the hormone-receptor status defines important clinical and etiologic differences. We review the epidemiologic data on differences in risk-factor associations by hormone-receptor status and highlight major trends in the literature. We discuss the development and evaluation of breast cancer risk models, with a focus on the Rosner and Colditz model, which can separately estimate the risk of hormone-receptor-positive and hormone-receptor-negative breast cancers. We also discuss the clinical implications of accounting for hormone-receptor status in breast cancer risk-prediction models.Keywords
This publication has 69 references indexed in Scilit:
- Concordance among Gene-Expression–Based Predictors for Breast CancerNew England Journal of Medicine, 2006
- Adult Weight Change and Risk of Postmenopausal Breast CancerJAMA, 2006
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Breast cancer risk factors according to joint estrogen receptor and progesterone receptor statusCancer Detection Prevention, 2005
- Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC)International Journal of Cancer, 2004
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Prognostic characteristics in breast cancers after hormone replacement therapyBreast Cancer Research and Treatment, 1996
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989
- Relation between estrogen receptor concentration and clinical and histological factors: Their relative prognostic importance after radical mastectomy for primary breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989